EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A new algorithm Precision OncoPanels (PrOPs) identifies short individualized actionable panels that can guide cancer treatment: a pan-cancer analysis of TCGA cohorts

Shrisruti Sriraman, Debajyoti Das, Nagasuma Chandra iD

NAR Genomics and Bioinformatics · 2025

DOI: 10.1093/nargab/lqaf177 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NAR Genomics and Bioinformatics, 2025. Verfasst von Shrisruti Sriraman und 2 weiteren Autor:innen. Beteiligte Einrichtung: IISc Mathematics Initiative, Indian Institute of Science, Bangalore 560012, India. Hauptthemen laut MEDLINE: Algorithms, Neoplasms, Precision Medicine. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Biotechnology, National Network Project grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Precision oncology, enabled by next-generation sequencing (NGS), has shown tremendous potential for use in a clinical setting for cancer diagnosis and treatment. The biggest promise is to make treatment more precise and tailored for individual patients, departing from the one-size-fits-all approach. However, the translation of genomic panels into clinical practice and their wider implementation are met with challenges. Currently, only those patients who have frequently observed mutations in that cancer benefit from the NGS approach. There is an urgent need to expand the scope of this to all patients, for which new methods are required to be developed so as to identify key actionable gene panels in all patients. We address this need and present a new algorithm, PrOPs (Precision Onco Panels), that identifies short actionable driver panels by integrating genomics, transcriptomics, genome-wide protein–protein interactions, and precision network construction and analysis. We tested the algorithm on 2180 patients from six cancer types from TCGA (BRCA, COAD, GBM, LIHC, LUAD, and SKCM) and predicted patient-specific cancer driver genes. PrOPs outperforms the existing network-based methods that identify personalized drivers and also capture rare and patient-specific cancer drivers. Among the clinical cohorts, PrOPs identified clinically relevant actionable panels in 93% of patient cases. The extensive testing of our algorithm and demonstrated generalizability in six different cancers indicate the usefulness of our algorithm in precision oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlgorithmsNeoplasmsPrecision MedicineHumansHigh-Throughput Nucleotide SequencingGenomicsMutationCohort Studies

Autor:innen und Institutionen

  • IISc Mathematics Initiative, Indian Institute of Science, Bangalore 560012, India.
  • Department of Biochemistry, Indian Institute of Science, Bangalore 560012, India.
  • Department of Bioengineering, Indian Institute of Science, Bangalore 560012, India.

ORCID-Profile: Nagasuma Chandra

Förderung

  • Department of Biotechnology
  • National Network Project grant

Zitieren

APA

Sriraman, S., Das, D., & Chandra, N. (2025). A new algorithm Precision OncoPanels (PrOPs) identifies short individualized actionable panels that can guide cancer treatment: a pan-cancer analysis of TCGA cohorts. NAR Genomics and Bioinformatics. https://doi.org/10.1093/nargab/lqaf177

Vancouver

Sriraman S, Das D, Chandra N. A new algorithm Precision OncoPanels (PrOPs) identifies short individualized actionable panels that can guide cancer treatment: a pan-cancer analysis of TCGA cohorts. NAR Genomics and Bioinformatics. 2025. doi:10.1093/nargab/lqaf177

BibTeX
@article{Sriraman2025,
  author = {Sriraman, Shrisruti and Das, Debajyoti and Chandra, Nagasuma},
  title = {A new algorithm Precision OncoPanels (PrOPs) identifies short individualized actionable panels that can guide cancer treatment: a pan-cancer analysis of TCGA cohorts},
  journal = {NAR Genomics and Bioinformatics},
  year = {2025},
  doi = {10.1093/nargab/lqaf177}
}
Kostenlos starten →